Literature DB >> 10422787

Molecular characterisation of cloned bradykinin B1 receptors from rat and human.

C Jones1, E Phillips, C Davis, J Arbuckle, M Yaqoob, G M Burgess, R J Docherty, M Webb, S J Bevan, P McIntyre.   

Abstract

This report describes the characterisation of cloned rat and human bradykinin B1 receptors in African green monkey kidney fibroblast (Cos-7) cells. A ligand binding assay with [3H]des-Arg10-kallidin was used to compare their pharmacology with respect to known bradykinin B1 and B2 receptor ligands. In addition, the pharmacology of T-kinin and its' derivative des-Arg11-T-kinin was investigated. The cloned rat receptor had a similar pharmacology to that of the recently described mouse receptor and differs from that described for the human receptor. The rat receptor had a higher affinity for des-Arg11-T-kinin than the human receptor. These differences in pharmacological properties may relate to the presence of T-kinin, bradykinin and their des-Arg derivatives as the major physiological peptides in rat and the predominance of kallidin and its derivatives in human. We confirm that the rat bradykinin B1 receptor gene is organised in a two exon structure and differs from the human gene which has a three exon structure and we further examine the inducible expression of this gene in a wide range of tissues using Northern blotting.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10422787     DOI: 10.1016/s0014-2999(99)00315-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Pharmacological characterization of the cardiovascular responses elicited by kinin B(1) and B(2) receptor agonists in the spinal cord of streptozotocin-diabetic rats.

Authors:  F Cloutier; R Couture
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Antihyperalgesic activity of a novel nonpeptide bradykinin B1 receptor antagonist in transgenic mice expressing the human B1 receptor.

Authors:  Alyson Fox; Satbir Kaur; Bifang Li; Moh Panesar; Uma Saha; Clare Davis; Ilaria Dragoni; Sian Colley; Tim Ritchie; Stuart Bevan; Gillian Burgess; Peter McIntyre
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia.

Authors:  G M Burgess; M N Perkins; H P Rang; E A Campbell; M C Brown; P McIntyre; L Urban; E K Dziadulewicz; T J Ritchie; A Hallett; C R Snell; R Wrigglesworth; W Lee; C Davis; S B Phagoo; A J Davis; E Phillips; G S Drake; G A Hughes; A Dunstan; G C Bloomfield
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

5.  Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen.

Authors:  Ulrich Hilgenfeldt; Christina Stannek; Martina Lukasova; Martina Schnölzer; Sabina Lewicka
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 6.  Advances in Understanding the Initial Steps of Pruritoceptive Itch: How the Itch Hits the Switch.

Authors:  Shirin Kahremany; Lukas Hofmann; Arie Gruzman; Guy Cohen
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 5.923

7.  Novel kinin B₁ receptor splice variant and 5'UTR regulatory elements are responsible for cell specific B₁ receptor expression.

Authors:  Faang Y Cheah; Svetlana Baltic; Suzanna E L Temple; Kanti Bhoola; Philip J Thompson
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.